CVALF (Covalon Technologies) Institutional Ownership: 0.16% (As of Jul. 09, 2026)


CVALF Covalon Technologies Ltd CVALF
83 GF Score
Price $1.51
GF Value $1.53
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Covalon Technologies Institutional Ownership?

Covalon Technologies CVALF -1.79% 83 Institutional Ownership is 0.16% as of Jul. 09, 2026. GuruFocus rates CVALF with a GF Score™ of 83/100 and a GF Value™ of $1.53 (Fairly Valued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Covalon Technologies's institutional ownership is 0.16%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Covalon Technologies's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Covalon Technologies's Float Percentage Of Total Shares Outstanding is 0.00%.


Covalon Technologies Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Covalon Technologies's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Covalon Technologies Institutional Ownership Chart

Covalon Technologies Historical Data

The historical data trend for Covalon Technologies can be seen below:

2019-01-31 2019-02-28 2019-03-31 2019-04-30 2019-05-31 2019-06-30 2019-07-31 2021-09-30 2021-10-31 2021-11-30
Institutional Ownership 0.27 0.38 1.26 1.35 1.71 1.71 1.62 0.16 0.16 0.16
CVALF
83GF Score
Covalon Technologies Ltd CVALF
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Covalon Technologies Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.16% mean?
Covalon Technologies (CVALF) has a Institutional Ownership of 0.16% as of Jul. 09, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Covalon Technologies and its competitors.
Is Covalon Technologies' Institutional Ownership too high?
Covalon Technologies' current Institutional Ownership is 0.16%. Overall, Covalon Technologies has a GF Score™ of 83/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Covalon Technologies' Institutional Ownership compare to ISRG and BDX?
Covalon Technologies' Institutional Ownership of 0.16% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Covalon Technologies and its competitors. Covalon Technologies's current Institutional Ownership is 0.16%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Covalon Technologies stock overvalued right now?
Based on GuruFocus' analysis, Covalon Technologies (CVALF) is currently considered Fairly Valued. The stock's GF Value™ is $1.53, compared to a current price of $1.51 — trading 1.3% below its estimated fair value. The current Institutional Ownership is 0.16%. Covalon Technologies' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Covalon Technologies (CVALF), the current Institutional Ownership is 0.16% as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Covalon Technologies (CVALF) Overvalued in 2026?

Based on GuruFocus' analysis, Covalon Technologies stock appears to be undervalued. The current stock price of $1.51 is trading 1.3% below its estimated GF Value™ of $1.53. GuruFocus considers Covalon Technologies to be Fairly Valued.

Key valuation signals for CVALF:

  • Institutional Ownership: 0.16%
  • GF Value™: $1.53 vs. price of $1.51 (1.3% below fair value)
  • GF Score™: 83/100 with 2 warning signs

No single metric tells the full story. See the CVALF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Covalon Technologies Business Description

Other Exchanges COV:Canada
Address 1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is engaged in the business of researching, developing, manufacturing, and marketing patent-protected medical products that improve patient outcomes in the areas of infection management, wound care, and surgical procedures. The company generates revenue through development contracts, licensing agreements, distribution contracts, and sales. Its products include IV dressings, surgical site protection products, vascular access protection products, and others, and its solutions include primary dressing cover, vascular access technologies, advanced wound care, sensitive skin solutions, custom medical coatings, and patient resource support.
83GF Score

Get the complete analysis for CVALF

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.51
Price
$1.53
GF Value